Impact of antiviral therapy for acute obstructive bronchitis in preschool children

E. Kondiurina (Novosibirsk, Russian Federation)

Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Session: Paediatric asthma: treatment modalities and behavioural issues
Session type: Poster Discussion
Number: 600
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Kondiurina (Novosibirsk, Russian Federation). Impact of antiviral therapy for acute obstructive bronchitis in preschool children. 600

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinico-immunological characteristics of acute and exacerbations of chronic bronchitis in youths
Source: Eur Respir J 2003; 22: Suppl. 45, 481s
Year: 2003

Cardiopulmonary effects of long-term bronchodilator therapy in patients with chronic obstructive bronchitis
Source: Eur Respir J 2001; 18: Suppl. 33, 483s
Year: 2001

Malnutrition in children with chronic bronchitis
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003

Pharmacodynamics of levofloxicin in patients with acute exacerbation of chronic bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002

Therapeutic responses in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008


Comparative evaluation of fluoroquinolone efficiency in treatment of infectious acute attack of chronic obstructive bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 512s
Year: 2004

Cost analysis for inpatient therapy in elderly patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 661s
Year: 2004

Efficacy and cardiovascular safety of long-term bronchodilator therapy with theophylline in patients with chronic obstructive bronchitis (COB)
Source: Eur Respir J 2003; 22: Suppl. 45, 52s
Year: 2003

Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea
Source: Eur Respir J 2005; 26: Suppl. 49, 285s
Year: 2005

Oral nutritional supplementation during hospitalization for an acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 593s
Year: 2002

Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010

Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002

Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006

Prevalence of chronic obstructive bronchitis (COB) among French adults
Source: Eur Respir J 2001; 18: Suppl. 33, 274s
Year: 2001

Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease?
Source: Annual Congress 2003 - COPD: risk factors and course of disease
Year: 2003


Antibiotics in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Efficacy and safety of various antimicrobial regimens in the treatment of acute exacerbations of chronic bronchitis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007


Adherence with inhaled respiratory therapeutics is associated with reduced acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD: integrated care and rehabilitation
Year: 2011